What is Regranex used to treat? This medication is used to treat certain foot/leg ulcers in people with diabetes. It is used along with good foot/leg care (e.g., keeping pressure off the wound) to help
What is Regranex used to treat?
This medication is used to treat certain foot/leg ulcers in people with diabetes. It is used along with good foot/leg care (e.g., keeping pressure off the wound) to help the ulcer heal completely. Becaplermin works by attracting certain natural substances to the ulcer that help wound healing.
How long does it take for Regranex to work?
The cost of becaplermin is substantial at $586 per 15-g tube, which will provide treatment for a 2 cm2 ulcer for approximately four weeks. Treatment generally will take at least 10 weeks, necessitating two to three tubes per treatment course.
Is there a generic for Regranex?
Regranex is a brand-name prescription drug. There is no generic version available.
How often should the dosing of Regranex be recalculated?
The amount of REGRANEX Gel to be applied should be recalculated by the physician or wound caregiver at weekly or biweekly intervals depending on the rate of change in ulcer area. The weight of REGRANEX Gel from 15g tubes is 0.65g per inch length and 0.25g per centimeter length.
How is Regranex calculated?
Adult Dosage: Length of gel (in cm) to be applied daily = (length x width of wound area in cm2) ÷ 4. Or, length of gel (in inches) to be applied daily = (length x width of wound area in inches2) x 0.6. Squeeze calculated length of gel from tube onto clean measuring surface (eg, wax paper).
How do you use Regranex?
Apply REGRANEX one time a day to ulcer area. Do not use more than your prescribed dose of REGRANEX or apply more often than every 24 hours. Do not let the tip of your REGRANEX tube touch the ulcer or any other surface. Put the REGRANEX tube in the refrigerator after each use.
How often is Regranex applied?
REGRANEX should be applied once daily to the ulcer until complete healing has occurred. If the ulcer does not decrease in size by approximately 30% after 10 weeks of treatment or complete healing has not occurred in 20 weeks, continued treatment with REGRANEX should be reassessed.
When do you use Regranex?
REGRANEX is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply, when used as an adjunct to, and not a substitute for, good ulcer care practices including initial sharp debridement, pressure relief and infection …
How do you use REGRANEX?
How much does REGRANEX cost?
The cost for Regranex topical gel 0.01% is around $1,297 for a supply of 15 grams, depending on the pharmacy you visit….Topical Gel.
| Quantity | Per unit | Price |
|---|---|---|
| 15 grams | $86.47 | $1,297.07 |
Does Regranex need to be refrigerated?
REGRANEX Gel is for external use only. Store refrigerated, 2-8°C (36-46°F). DO NOT FREEZE. DO NOT USE THE GEL AFTER THE EXPIRATION DATE AT THE BOTTOM OF THE TUBE.
Are there any side effects to taking Regranex?
Adverse Reactions: In clinical trials, erythematous rashes occurred in 2% of subjects treated with REGRANEX (and good ulcer care) or placebo (and good ulcer care).
When to use Regranex for lower extremity ulcers?
Regranex (becaplermin) Gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply, when used as an adjunct to, and not a substitute for, good ulcer care practices including initial sharp debridement, pressure relief and infection control.
How is Regranex gel used in wound care?
In clinical studies, using REGRANEX gel as part of effective ulcer care: Helped to achieve wound closure an average 6 weeks earlier than placebo gel* 5 Significantly increased the incidence of complete closure by 43%, when compared to placebo gel** 5 Shown to help stimulate the recruitment and proliferation of cells involved in wound repair 6
How many cancer patients have been diagnosed with Regranex?
In a retrospective follow-up study, eight of 291 subjects (2.7%) from the REGRANEX group, and two of 200 subjects (1%) from the placebo group were diagnosed with cancers during the follow-up period.